PARK Park Dental Partners, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$19.84
· of 52w range
· above low
· to high
$9.5352w low
$26.7952w high
Market Cap (MRQ)
$93M
your badges
52W Range
$10–$27
Analyst Rating
BUY
Price Target
$28
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
PARK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$19.84
Market Cap (MRQ)
$93M
Debt/Equity (MRQ)
0.4
52W Range
$10–$27
PARK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PARK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 3.1 | · | 2.3 | Overvalued | |
| Price / Tangible Book (MRQ) | 5.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PARK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.4 | · | 0.2 | Above avg | |
| Current Ratio (MRQ) | 1.1 | · | 1.0 | In line | |
| Long-Term Debt / Equity (MRQ) | 0.3 | · | 0.2 | High debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
267.3%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $0.66 | $0.34 | 96.1% |
| March 31, 2026 | May 13, 2026 | $0.44 | $0.20 | 115.7% |
| Dec. 31, 2025 | $0.30 | $-0.06 | 590.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $25M | |
| Receivables | $7M | |
| Inventory | $930.0K | |
| Prepaid Expense | $2M | |
| Current Assets | $38M | |
| Goodwill | $17M | |
| Intangibles | $11M | |
| Total Assets | $178M | |
| Current Liabilities | $36M | |
| Capital Leases | $42M | |
| Other Non-current Liabilities | $486.0K | |
| Total Liabilities | $156M | |
| Long-term Debt | $12M | |
| Common Stock | $1.0K | |
| Retained Earnings | $-6M | |
| Treasury Stock | $737.0K | |
| Stockholders' Equity | $22M | |
| Liabilities + Equity | $178M | |
| Shares Outstanding | 4,247,018 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $66M | $63M | $63M | $59M | |
| Cost of Revenue | $57M | $56M | $51M | $49M | |
| Gross Profit | $10M | $6M | $12M | $10M | |
| SG&A Expense | $8M | $8M | $7M | $7M | |
| Operating Income | $1M | $-2M | $4M | $3M | |
| Pretax Income | $1M | $-2M | $4M | $2M | |
| Income Tax | $-230.0K | $-2M | $1M | $646.0K | |
| Net Income | $1M | $-390.0K | $3M | $2M | |
| EPS (Basic) | $0.30 | $-0.09 | $1.45 | $0.88 | |
| EPS (Diluted) | $0.22 | $-0.09 | $1.45 | $0.88 | |
| Shares (Basic) | 4,571,346 | 4,383,073 | 1,772,662 | 1,783,352 | |
| Shares (Diluted) | 6,235,305 | 4,383,073 | 1,772,662 | 1,783,352 | |
| EBITDA | $1M | $503.0K | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $24M | · | · | |
| Receivables | $8M | $7M | · | · | |
| Inventory | $959.0K | $949.0K | · | · | |
| Prepaid Expense | $4M | $3M | · | · | |
| Current Assets | $40M | $38M | · | · | |
| Goodwill | $17M | $17M | · | · | |
| Intangibles | $13M | $12M | · | · | |
| Total Assets | $186M | $180M | · | · | |
| Current Liabilities | $35M | $35M | · | · | |
| Capital Leases | $42M | $41M | · | · | |
| Other Non-current Liabilities | $659.0K | $537.0K | · | · | |
| Total Liabilities | $156M | $154M | · | · | |
| Long-term Debt | $11M | $12M | · | · | |
| Total Debt | $11M | $12M | · | · | |
| Common Stock | $1.0K | $1.0K | · | · | |
| Retained Earnings | $-5M | $-6M | · | · | |
| Treasury Stock | $737.0K | $737.0K | · | · | |
| Stockholders' Equity | $30M | $25M | · | · | |
| Liabilities + Equity | $186M | $180M | · | · | |
| Shares Outstanding | 4,704,780 | 4,515,054 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $3M | $4M | · | · | |
| Deferred Tax | $-497.0K | $-470.0K | · | · | |
| Other Non-cash | · | $-521.0K | · | · | |
| Operating Cash Flow | $5M | $5M | $3M | $6M | |
| CapEx | $2M | $2M | $2M | $2M | |
| Investing Cash Flow | $-3M | $-5M | $-3M | $-3M | |
| Net Debt Issued | · | $-473.0K | · | · | |
| Financing Cash Flow | $-1M | $-1M | $-1M | $-2M | |
| Free Cash Flow | · | $3M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Gross Margin | 14.4% | 10.2% | · | · | |
| Operating Margin | 1.9% | -3.0% | · | · | |
| Net Margin | 2.0% | -0.62% | · | · | |
| Pretax Margin | 1.7% | -3.2% | · | · | |
| EBITDA Margin | 1.9% | 0.80% | · | · | |
| ROA | 1.5% | -0.43% | · | · | |
| ROE | 9.0% | -3.1% | · | · | |
| ROIC | 3.7% | -0.99% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | · | |
| Debt / Equity | 0.4 | 0.5 | · | · | |
| LT Debt / Equity | 0.3 | 0.4 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | · | |
| Inventory Turnover | 118.2 | 118.7 | · | · | |
| Receivables Turnover | 16.7 | 18.4 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Book Value / Share | $6.34 | $5.63 | · | · | |
| Revenue / Share | $10.62 | $14.30 | · | · | |
| Cash Flow / Share | · | $1.15 | · | · | |
| Cash / Share | $5.19 | $5.40 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Market Cap | $101M | $76M | · | · | |
| Enterprise Value | $88M | $63M | · | · | |
| P/B | 3.4 | 3.0 | · | · | |
| P / Cash Flow | · | 15.1 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 24 filers · $23.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
24
Value held
$23.7M
New positions
7
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (-2 vs prior Q) | 3 (+3 vs prior Q) | 9 (+6 vs prior Q) | 5 (0 vs prior Q) | +251K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| KENNEDY CAPITAL MANAGEMENT LLC | $5,103,148 | 236,805 | 21.49% | Shares |
| HEARTLAND ADVISORS INC | $4,310,000 | 200,000 | 18.15% | Shares |
| Pacific Ridge Capital Partners, LLC | $3,722,719 | 172,748 | 15.68% | Shares |
| Russell Investments Group, Ltd. | $1,899,945 | 88,164 | 8.00% | Shares |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $1,444,281 | 67,020 | 6.08% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,431,265 | 66,416 | 6.03% | Shares |
| CITADEL ADVISORS LLC | $1,151,826 | 53,449 | 4.85% | Shares |
| ACCESS FINANCIAL SERVICES, INC. | $1,070,755 | 49,687 | 4.51% | Shares |
| ROYAL BANK OF CANADA | $958,000 | 44,464 | 4.03% | Shares |
| MARSHALL WACE, LLP | $533,471 | 24,755 | 2.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $448,088 | 20,793 | 1.89% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $400,830 | 18,600 | 1.69% | Shares |
| SEI INVESTMENTS CO | $346,028 | 16,057 | 1.46% | Shares |
| Boston Partners | $285,390 | 13,243 | 1.20% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $260,389 | 12,083 | 1.10% | Shares |
| Quadrature Capital Ltd | $221,340 | 10,271 | 0.93% | Shares |
| BlackRock, Inc. | $120,357 | 5,585 | 0.51% | Shares |
| JPMORGAN CHASE & CO | $13,638 | 648 | 0.06% | Shares |
| MORGAN STANLEY | $10,775 | 500 | 0.05% | Shares |
| Tower Research Capital LLC (TRC) | $4,633 | 215 | 0.02% | Shares |
| CITIGROUP INC | $4,245 | 197 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $2,155 | 100 | 0.01% | Shares |
| BARCLAYS PLC | $1,767 | 82 | 0.01% | Shares |
| Smartleaf Asset Management LLC | $1,221 | 58 | 0.01% | Shares |
Company insiders 8 insiders · 4 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Peter G Swenson | CEO and Chairman | June 15, 2026 A | 238,381 | 2 | 0 | $91,195 |
| Christopher James Bernander | Chief Financial Officer | June 15, 2026 A | 55,756 | 1 | 0 | $24,999 |
| Alan Siems Law | Chief Clinical Officer - Specialty Practices | Aug. 25, 2026 G | 180,961 | 1 | 0 | $24,999 |
| Christopher Eugene Steele | Chief Clinical Officer - General Practices | June 15, 2026 A | · | 0 | 0 | $0 |
| Christopher Charles Smith | Director | June 15, 2026 A | 10,492 | 1 | 0 | $99,996 |
| Anna Marie Schaefer | Director | June 15, 2026 A | · | 0 | 0 | $0 |
| Philip Irving Smith | Director | June 15, 2026 A | 3,569 | 1 | 0 | $9,997 |
| Todd Christopher Gerlach | Director | Dec. 3, 2025 P | 68,847 | 1 | 0 | $99,996 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
PARK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$28.50
+43.6%
2 25.0%
Strong Buy
5 62.5%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-27Mean target $28.50 +43.6%
← Below all targets
Current price $19.84
Low$27.00
Mean$28.50
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026